dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.contributor | Pontifícia Universidade Católica de São Paulo (PUC-Sorocaba) | |
dc.date.accessioned | 2018-12-11T17:20:58Z | |
dc.date.available | 2018-12-11T17:20:58Z | |
dc.date.created | 2018-12-11T17:20:58Z | |
dc.date.issued | 2018-05-01 | |
dc.identifier | Anais Brasileiros de Dermatologia, v. 93, n. 3, p. 451-453, 2018. | |
dc.identifier | 1806-4841 | |
dc.identifier | 0365-0596 | |
dc.identifier | http://hdl.handle.net/11449/176483 | |
dc.identifier | 10.1590/abd1806-4841.20187419 | |
dc.identifier | S0365-05962018000300451 | |
dc.identifier | 2-s2.0-85048821475 | |
dc.identifier | S0365-05962018000300451.pdf | |
dc.description.abstract | Hypereosinophilic syndrome is defined as persistent eosinophilia (>1500/µL for more than six months) associated with organ involvement, excluding secondary causes. It is a rare, potentially lethal disease that should be considered in cutaneous conditions associated with hypereosinophilia. We report a case of erythroderma as a manifestation of hypereosinophilic syndrome. A 36-year-old male with no comorbidities presented progressive erythroderma, pruritus, peripheral neuropathy, and eosinophilia in the previous seven months. No mutations were found in FIP1L1/PDGFRA. Patient experienced rapid remission in response to oral prednisone and hydroxyurea. Cutaneous manifestations may be the only evidence of hypereosinophilic syndrome. Genotyping excludes myeloproliferative disease, thereby orienting treatment and prognosis. | |
dc.language | eng | |
dc.relation | Anais Brasileiros de Dermatologia | |
dc.relation | 0,520 | |
dc.rights | Acesso aberto | |
dc.source | Scopus | |
dc.subject | Dermatitis | |
dc.subject | Eosinophilia | |
dc.subject | Exfoliative | |
dc.subject | Polyneuropathies | |
dc.title | Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome | |
dc.type | Artículos de revistas | |